Fever-Tree Profits Decline Amid Packaging Tax Legal Battle
Premium drinks mixer company Fever-Tree has reported a significant 16 per cent slump in its annual profits, with underlying earnings falling to £42.4 million for 2025 from £50.7 million the previous year. The firm attributes this downturn primarily to a contentious £2.8 million packaging tax provision and ongoing integration expenses from its strategic US partnership with beverage giant Molson Coors.
Legal Challenge Over Extended Producer Responsibility Levy
At the heart of the financial setback is a formal legal dispute with the Environment Agency. Fever-Tree is challenging the Extended Producer Responsibility (EPR) packaging tax, arguing that specific glass bottles supplied to bars and restaurants should be exempt from the levy. The company has set aside the £2.8 million provision in anticipation of a potential loss in this case, citing accounting prudence due to the uncertain outcome.
"This is in line with the position taken by the UK government in relation to other packaging regulations," the group stated. "As previously disclosed, the Environment Agency has challenged this view, and in recent weeks we have launched a formal legal challenge."
Impact of Molson Coors Partnership Integration
Further pressuring earnings are the short-term costs associated with bedding in the US alliance with Molson Coors. The American beer maker acquired a stake in Fever-Tree last year, securing exclusive rights to market its premium mixers across the United States. However, the transition has introduced profit margin pressures from "short-term transition-related cost inefficiencies alongside the impact of sharing US profits."
Additionally, Fever-Tree noted a tariff impact as it manufactures most US products in the UK after terminating a local bottling contract ahead of the Molson Coors deal. The company is actively working to mitigate these effects ahead of planned onshoring of US production in the medium term, which it believes will unlock significant incremental profitability through Molson Coors' operational scale.
Financial Performance Overview
The full financial results reveal that pre-tax profits dropped to £29.9 million from £35.5 million in 2024. Despite this, underlying revenues showed a modest 3 per cent increase on a constant currency basis, reaching £375.3 million. This juxtaposition highlights the dual challenges of regulatory disputes and partnership integration costs overshadowing top-line growth.
Looking forward, Fever-Tree remains focused on resolving the packaging tax litigation and optimizing its US operations. The firm expressed confidence that the Molson Coors collaboration, once fully integrated, will enhance long-term profitability through improved economies of scale and market penetration in the competitive American beverage sector.
